SCHEMBL23458018

SCHEMBL23458018

CCN(c1c(C)ccc2ccccc12)C(C)C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 5/20 0.44
CYP2A6 P11509 3/20 0.44
TSHR P16473 3/20 0.44
ALDH1A1 P00352 4/20 0.38
CYP2D6 P10635 1/20 0.37
CYP2C19 P33261 1/20 0.36
PSEN1 P49768 1/20 0.36
PSEN2 P49810 1/20 0.36
APH1B Q8WW43 1/20 0.36
NCSTN Q92542 1/20 0.36
APH1A Q96BI3 1/20 0.36
PSENEN Q9NZ42 1/20 0.36
HTR2A P28223 1/20 0.36
HTR2C P28335 1/20 0.36
HSD17B10 Q99714 2/20 0.35
TDP1 Q9NUW8 2/20 0.35
HPGD P15428 1/20 0.35
KDM4E B2RXH2 2/20 0.35
KMT2A Q03164 2/20 0.35
LMNA P02545 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29862412 1.00 CYP1A2 (0.44) CYP1A2CYP2A6TSHRALDH1A1CYP2D6
SCHEMBL29862382 0.82 ATM (0.37) CYP1A2CYP2A6TSHRALDH1A1CYP2D6
SCHEMBL23457952 0.82 CYP1A2 (0.36) CYP1A2CYP2A6TSHRALDH1A1CYP2D6
SCHEMBL23458009 0.82 ATM (0.37) CYP1A2CYP2A6TSHRALDH1A1CYP2D6
SCHEMBL29862416 0.82 CYP1A2 (0.36) CYP1A2CYP2A6TSHRALDH1A1CYP2D6
SCHEMBL29862275 0.80 CYP1A2 (0.35) CYP1A2CYP2A6TSHRALDH1A1CYP2D6
SCHEMBL14283527 0.79 CYP1A2 (0.50) CYP1A2CYP2A6TSHRALDH1A1CYP2D6
SCHEMBL23458378 0.77 CYP1A2 (0.48) CYP1A2CYP2A6TSHRALDH1A1CYP2D6
SCHEMBL23458223 0.77 TSHR (0.48) CYP1A2CYP2A6TSHRALDH1A1CYP2D6
SCHEMBL29862287 0.77 CYP1A2 (0.48) CYP1A2CYP2A6TSHRALDH1A1CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12510529-B2 Method for determining authenticity and adulteration of marked petroleum hydrocarbons SICPA HOLDING SA (CH) 2025-12-30 US disclosed
EP-4069806-B1 METHOD OF MARKING A PETROLEUM HYDROCARBON SICPA HOLDING SA (CH) 2025-04-16 EP disclosed
US-20240327736-A1 METHOD OF MARKING A PETROLEUM HYDROCARBON SICPA HOLDING SA (CH) 2024-10-03 US disclosed
US-12031098-B2 Method of marking a petroleum hydrocarbon SICPA HOLDING SA (CH) 2024-07-09 US disclosed
EP-4069807-B1 METHOD FOR DETERMINING AUTHENTICITY AND ADULTERATION OF MARKED PETROLEUM HYDROCARBONS SICPA HOLDING SA (CH) 2023-10-04 EP disclosed
US-20230103579-A1 METHOD FOR DETERMINING AUTHENTICITY AND ADULTERATION OF MARKED PETROLEUM HYDROCARBONS SICPA HOLDING SA (CH) 2023-04-06 US disclosed
US-20230029106-A1 METHOD OF MARKING A PETROLEUM HYDROCARBON SICPA HOLDING SA (CH) 2023-01-26 US disclosed
WO-2021110525-A1 METHOD FOR DETERMINING AUTHENTICITY AND ADULTERATION OF MARKED PETROLEUM HYDROCARBONS SICPA HOLDING SA (CH) 2021-06-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12510529-B2 Method for determining authenticity and adulteration of marked petroleum hydrocarbons CYP4A11, CYP11B1, CYP11A1 CYP1A2 57/4885CYP2A6 75/4885TSHR 2195/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.